Cargando…

Dose surface maps of the heart can identify regions associated with worse survival for lung cancer patients treated with radiotherapy

BACKGROUND AND PURPOSE: For lung cancer patients treated with radiotherapy, radiation dose to the heart has been associated with overall survival, with volumetric dose statistics widely presented. However, critical cardiac structures are present on the hearts surface, where this approach may be sub-...

Descripción completa

Detalles Bibliográficos
Autores principales: McWilliam, Alan, Dootson, Chloe, Graham, Lewis, Banfill, Kathryn, Abravan, Azadeh, van Herk, Marcel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807666/
https://www.ncbi.nlm.nih.gov/pubmed/33458326
http://dx.doi.org/10.1016/j.phro.2020.07.002
_version_ 1783636790530277376
author McWilliam, Alan
Dootson, Chloe
Graham, Lewis
Banfill, Kathryn
Abravan, Azadeh
van Herk, Marcel
author_facet McWilliam, Alan
Dootson, Chloe
Graham, Lewis
Banfill, Kathryn
Abravan, Azadeh
van Herk, Marcel
author_sort McWilliam, Alan
collection PubMed
description BACKGROUND AND PURPOSE: For lung cancer patients treated with radiotherapy, radiation dose to the heart has been associated with overall survival, with volumetric dose statistics widely presented. However, critical cardiac structures are present on the hearts surface, where this approach may be sub-optimal. In this work we present a methodology for creating cardiac surface dose maps and identify regions where excess dose is associated with in worse overall survival. MATERIAL AND METHODS: A modified cylindrical coordinate system was implemented to map the cardiac surface dose for lung cancer patients. Validation was performed by mapping the cardiac chambers for 55 patients, fitting a point spread function (PSF) to the blurred edge. To account for this uncertainty, dose maps were blurred by a 2D-Gaussian with width described by the PSF. Permutation testing identified regions where excess dose was associated with worse patient survival. The 99th percentile of the max t-value then defined a cardiac surface region to extract dose, from each patient, to be analysed in a multivariable cox-proportional hazards survival model. RESULTS: Cardiac surface maps were created for 648 lung cancer patients. Cardiac surface dose maps were blurred with a 2D- Gaussian filter of size σ(φ) = 4.3° and σ(y) = 1.3units to account for mapping uncertainties. Permutation testing identified significant differences across the surface of the right atria, p < 0.001, at all timepoints. The median dose to the region defined by the 99th percentile of the maximum t-value was 18.5 Gy. Multivariable analysis showed the dose to this region was significantly associated with survival, hazard ratio 1.01 Gy(−1), p = 0.03, controlling for confounding variables. CONCLUSIONS: Cardiac surface mapping was successfully implemented and identified a region where excess dose was associated with worse patient survival. This region extended over the right atria, potentially suggesting an interaction with the hearts electrical conduction system.
format Online
Article
Text
id pubmed-7807666
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-78076662021-01-14 Dose surface maps of the heart can identify regions associated with worse survival for lung cancer patients treated with radiotherapy McWilliam, Alan Dootson, Chloe Graham, Lewis Banfill, Kathryn Abravan, Azadeh van Herk, Marcel Phys Imaging Radiat Oncol Original Research Article BACKGROUND AND PURPOSE: For lung cancer patients treated with radiotherapy, radiation dose to the heart has been associated with overall survival, with volumetric dose statistics widely presented. However, critical cardiac structures are present on the hearts surface, where this approach may be sub-optimal. In this work we present a methodology for creating cardiac surface dose maps and identify regions where excess dose is associated with in worse overall survival. MATERIAL AND METHODS: A modified cylindrical coordinate system was implemented to map the cardiac surface dose for lung cancer patients. Validation was performed by mapping the cardiac chambers for 55 patients, fitting a point spread function (PSF) to the blurred edge. To account for this uncertainty, dose maps were blurred by a 2D-Gaussian with width described by the PSF. Permutation testing identified regions where excess dose was associated with worse patient survival. The 99th percentile of the max t-value then defined a cardiac surface region to extract dose, from each patient, to be analysed in a multivariable cox-proportional hazards survival model. RESULTS: Cardiac surface maps were created for 648 lung cancer patients. Cardiac surface dose maps were blurred with a 2D- Gaussian filter of size σ(φ) = 4.3° and σ(y) = 1.3units to account for mapping uncertainties. Permutation testing identified significant differences across the surface of the right atria, p < 0.001, at all timepoints. The median dose to the region defined by the 99th percentile of the maximum t-value was 18.5 Gy. Multivariable analysis showed the dose to this region was significantly associated with survival, hazard ratio 1.01 Gy(−1), p = 0.03, controlling for confounding variables. CONCLUSIONS: Cardiac surface mapping was successfully implemented and identified a region where excess dose was associated with worse patient survival. This region extended over the right atria, potentially suggesting an interaction with the hearts electrical conduction system. Elsevier 2020-07-30 /pmc/articles/PMC7807666/ /pubmed/33458326 http://dx.doi.org/10.1016/j.phro.2020.07.002 Text en © 2020 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Research Article
McWilliam, Alan
Dootson, Chloe
Graham, Lewis
Banfill, Kathryn
Abravan, Azadeh
van Herk, Marcel
Dose surface maps of the heart can identify regions associated with worse survival for lung cancer patients treated with radiotherapy
title Dose surface maps of the heart can identify regions associated with worse survival for lung cancer patients treated with radiotherapy
title_full Dose surface maps of the heart can identify regions associated with worse survival for lung cancer patients treated with radiotherapy
title_fullStr Dose surface maps of the heart can identify regions associated with worse survival for lung cancer patients treated with radiotherapy
title_full_unstemmed Dose surface maps of the heart can identify regions associated with worse survival for lung cancer patients treated with radiotherapy
title_short Dose surface maps of the heart can identify regions associated with worse survival for lung cancer patients treated with radiotherapy
title_sort dose surface maps of the heart can identify regions associated with worse survival for lung cancer patients treated with radiotherapy
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807666/
https://www.ncbi.nlm.nih.gov/pubmed/33458326
http://dx.doi.org/10.1016/j.phro.2020.07.002
work_keys_str_mv AT mcwilliamalan dosesurfacemapsoftheheartcanidentifyregionsassociatedwithworsesurvivalforlungcancerpatientstreatedwithradiotherapy
AT dootsonchloe dosesurfacemapsoftheheartcanidentifyregionsassociatedwithworsesurvivalforlungcancerpatientstreatedwithradiotherapy
AT grahamlewis dosesurfacemapsoftheheartcanidentifyregionsassociatedwithworsesurvivalforlungcancerpatientstreatedwithradiotherapy
AT banfillkathryn dosesurfacemapsoftheheartcanidentifyregionsassociatedwithworsesurvivalforlungcancerpatientstreatedwithradiotherapy
AT abravanazadeh dosesurfacemapsoftheheartcanidentifyregionsassociatedwithworsesurvivalforlungcancerpatientstreatedwithradiotherapy
AT vanherkmarcel dosesurfacemapsoftheheartcanidentifyregionsassociatedwithworsesurvivalforlungcancerpatientstreatedwithradiotherapy